ESGO Statement on the Role of CA/125 Measurement in Follow-Up of Epithelial Ovarian Cancer

被引：6
|
作者：
van der Zee, Ate G. J. [1 ]
Colombo, Nicoletta [1 ]
Gitsch, Gerald [1 ]
Reed, Nicolas [1 ]
Amant, Frederic [1 ]
Cibula, David [1 ]
Kesic, Vesna I. [1 ]
Kimmig, Rainer [1 ]
Lopes, Alberto D. B. [1 ]
Markowska, Janina [1 ]
Marth, Christian [1 ]
Radolakis, Alexander [1 ]
Salvesen, Helga [1 ]
Vaitkiene, Daiva [1 ]
Verheijen, Rene H. M. [1 ]
Zola, Paolo [1 ]
机构：
[1] Univ Groningen, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2012年 / 22卷 / 01期
关键词：
D O I：
10.1097/IGC.0b013e3182261f15
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：175 / 175
页数：1
相关论文
共 50 条
  • [31] LONG-TERM FOLLOW-UP OF OVARIAN-CANCER WITH MONTHLY DETERMINATIONS OF SERUM CA-125
    HOGBERG, T
    KAGEDAL, B
    GYNECOLOGIC ONCOLOGY, 1992, 46 (02) : 191 - 198
  • [32] Monitoring ovarian cancer patients during chemotherapy and follow-up with the serum tumor marker CA125
    Abu Hassaan, Suher Othman
    DANISH MEDICAL JOURNAL, 2018, 65 (04):
  • [33] THE ROLE OF CANCER ANTIGEN-125 (CA-125) IN THE MANAGEMENT OF OVARIAN EPITHELIAL CARCINOMAS
    ALTARAS, MM
    GOLDBERG, GL
    LEVIN, W
    RADIO, FF
    BLOCH, B
    DARGE, L
    SMITH, JA
    GYNECOLOGIC ONCOLOGY, 1988, 30 (01) : 26 - 34
  • [34] 18F-FDG PET/CT imaging combined with serum CA125 test in the follow-up of treated epithelial ovarian cancer
    Zhu, Z.
    Xie, Q.
    Zhu, X.
    Wang, X.
    Pan, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S566 - S567
  • [35] CA-125 immunoassay: any useful role in follow-up of endometriosis?
    Al-Omari, W
    FERTILITY AND STERILITY, 2002, 77 (02) : S51 - S51
  • [36] Tissue quantification of CA 125 in epithelial ovarian cancer
    De la Cuesta, R
    Maestro, ML
    Solana, J
    Vidart, JA
    Escudero, M
    Iglesias, E
    Valor, R
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 1999, 14 (02): : 106 - 114
  • [37] Is there a role for follow-up CT in the management of treated ovarian cancer?
    Clarkson, LM
    Hennig, IM
    Sanderson, A
    Hall, GD
    Perren, TJ
    Spencer, JA
    RADIOLOGY, 2002, 225 : 598 - 598
  • [38] A study to evaluate the use of CA125 in ovarian cancer follow-up: A change in practice led by patient preference
    Palmer, C
    Pratt, J
    Basu, B
    Earl, H
    GYNECOLOGIC ONCOLOGY, 2006, 101 (01) : 4 - 11
  • [39] RELEVANCE OF CA125, PLATELET COUNT AND NEUTROPHIL TO LYMPHOCYTE RATIO IN THE DIAGNOSIS AND FOLLOW-UP OF OVARIAN CANCER PATIENTS
    Baert, T.
    Vanbrabant, L.
    Laenen, A.
    Vergote, I.
    Coosemans, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1427 - 1427
  • [40] How relevant is the CA-125 monitoring for patients with ovarian cancer in the follow-up? Results from a multicenter survey in 1060 patients with ovarian cancer
    Oskay-Ozcelik, G.
    du Bois, A.
    Fasching, P. A.
    Mahner, S.
    Liebrich, C.
    Glass, A.
    Schmidt-Wetzel, S.
    Muenstedt, C.
    Lichtenegger, W.
    Sehouli, J.
    EJC SUPPLEMENTS, 2009, 7 (02): : 466 - 466
12345